Pharma & Biotech News #PharmaBuzz

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Weekly News Recap #Phispers

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

In Phispers this week, Indian drugmaker Sun Pharmaceutical acquired Jersey-based Organon in an all-cash deal valued at about US...

Impressions : 1566

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

Eli Lilly has been on an acquisition spree this year. After buying Ventyx Biosciences, Orna Therapeutics, CrossBridge Bio, and...

Impressions : 1394

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

This week’s Phispers brings you news on how artificial intelligence (AI) is taking centerstage in the world of pharmaceut...

Impressions : 2125

Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly's Foundayo in cross-trial comparison

In Phispers this week, Neurocrine Biosciences announced the acquisition of rare-disease drugmaker Soleno Therapeutics for US$ ...

Impressions : 1356

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly's Foundayo in cross-trial comparison

Aizant's Generics Eltrombopag Olamine Receives Approval in US

Sun Pharma Canada's Generics Doxepin HCl Receives Approval in US

Micro's Generics Ticagrelor Receives Approval in US

Astrazeneca's Biologics Saphnelo Receives Approval in US

Alembic's Generics Fingolimod HCl Receives Approval in US

Navinta's Generics Glycerol Phenylbutyrate Receive Approval in US

Teva' Generics Budesonide & Formoterol Receives Approval in US

ScieGen Pharms' Generics Valsartan Receives Approval in US

Hainan's Generics Tigecycline Receives Tentative Approval in US

Cipla's Generics Albuterol Sulfate Receives Approval in US

Intas' Receives FDA Warning Letter

Lexia's Receives FDA Warning Letter

B. Braun Issues Voluntary Recall of Lactated Ringer's Injection

Enforcement Report - Week of April 22, 2026

Veyx-Pharma B.V. Production Fails EDQM Inspection

Produlab Pharma Production Fails EDQM Inspection

Thrive Health and Wellness' Receives FDA Warning Letter

Xiamen Kang Zhongyuan Biotechnology's Receives FDA Warning Letter

Apollo Care's Receives FDA Warning Letter

UCSF Radiopharmaceutical Facility's Receives FDA Warning Letter

Carlylebuys RCM Providers Knack & Equalize For $600 Million

Pharma Exports Exceed $31B In FY26 Amid Global Challenges

Biomarin Unveils Q1 2026 Financial And Operating Results

Viatris Announces Chief Financial Officer Transition

Biohaven Reports Q1 2026 Results and Recent Business Updates

Biotech firm Odyssey targets $810 million valuation in US IPO

Celcuity's gedatolisib beats Novartis' Piqray in phase 3

Gyre Therapeutics Completes Acquisition of Cullgen

Mirum's rare liver Disease Drug Meets Main Goal in Mid-Stage

Supreme Court Restores Mifepristone Access By Mail

OneSource Partners Win Health Canada Nod for Generic Semaglutide

Mapi Pharma Eyes U.S. Aseptic Plant for Long-Acting Injectables

Accord Healthcare US Relaunches Tadalafil Tablets

GTRI: India Supplies 20% of Global Generics, WTO-Compliant IP

Novo Nordisk Launches Ozempic Oral Pill For Type 2 Diabetes

Aurobindo Pharma's Curateq Receives Health Canada Approval

Apotex First Canadian Pharma Co. To Get Health Canada Approval

U.S. Supreme Court Examines Skinny-label Generics Limits

Teva Beats Earnings on Branded Drugs as Generics Falter

Dr Reddy's Laboratories Receives Approval From Health Canada

Biohaven Reports Q1 2026 Results and Recent Business Updates

Biotech firm Odyssey targets $810 million valuation in US IPO

Celcuity's gedatolisib beats Novartis' Piqray in phase 3

Gyre Therapeutics Completes Acquisition of Cullgen

Sanofi Invests $294M in Toronto AI Excellence Center

Vertex Drop mRNA Cystic Fibrosis Program Over Tolerability Issues

Ironwood DDW Survey Highlights TPN Burden in Short Bowel Syndrome

Researchers Find Two-Drug Combo to Fight Triple-Neg Breast Cancer

Gene Therapy's Evidence Problem—Lessons From Recent FDA Decisions

Cartesian Therapeutics Announces New Employment Inducement Grants

Polyrizon Expands U.S. Patent for Intranasal Delivery Platform

JP Nadda Highlights India's Focus on APIs and Biologics Research

Wanbury Clears Korea FDA Inspection At Patalganga Site

Solara Completes US FDA Inspection At Puducherry Site

RPG Life Sciences Expands API Business, Targets GLP-1 Entry

Formosa Pharma Partners with SERI on Corneal Diseases

Onco-Innovations Scales Up API Materials for PNKP Program

C-Ray Receives FDA Acceptance of Type2 DMF for Copper-64 (Cu-64)

Akums Launches Aztreonam-Avibactam to Fight Resistant Infections

Chinese API Surge Strains Indian Pharma Amid Mideast Crisis

Alkem Labs Gets 7 FDA Observations After Daman Site Inspection

Supreme Court Ask to Intervene in Mail-order Abortion pill fight

NAFDAC Warns of Fake Augmentin 625mg in Nigeria

Several State Still Not File NSQ Data with Central Drug Regulator

InspireMD Initiates Voluntary Recall of CGuard Delivery System

ORS Sales Melt In March After Govt's Stricter Labelling Norms

Patient death prompts FDA pause on Newron's Phase 3 schizophrenia

Leanzene Gummies Under Investigation Avoid Fake Complaints & Risk

House Panel Urges Ban on China Data in FDA Approvals

FDA Proposes Excluding Semaglutide, Tirzepatide, Liraglutide

Niagen Bioscience Launches Telehealth Platform With Injection Kit

Three Cruise Ship Passengers Die In Suspected Hantavirus Outbreak

Sanford Burnham Wins $3.9M NIH Grant for Non-Opioid Development